The overexpression of another ncRNA, lncRNA VPS9D1-AS1, a potential prognostic marker, can be used to predict poor prognosis in NSCLC (70), and its role in cancer has been validated (71, 72). This evidence concerns the gene VPS9D1 and non-small cell lung carcinoma.